22-29260747-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012265.3(RHBDD3):c.650C>T(p.Pro217Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000344 in 1,598,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012265.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHBDD3 | NM_012265.3 | c.650C>T | p.Pro217Leu | missense_variant | 5/7 | ENST00000216085.12 | NP_036397.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHBDD3 | ENST00000216085.12 | c.650C>T | p.Pro217Leu | missense_variant | 5/7 | 1 | NM_012265.3 | ENSP00000216085.7 | ||
RHBDD3 | ENST00000413137.6 | n.*226C>T | non_coding_transcript_exon_variant | 5/7 | 5 | ENSP00000399550.2 | ||||
RHBDD3 | ENST00000496342.1 | n.689C>T | non_coding_transcript_exon_variant | 2/3 | 2 | |||||
RHBDD3 | ENST00000413137.6 | n.*226C>T | 3_prime_UTR_variant | 5/7 | 5 | ENSP00000399550.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152004Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000317 AC: 7AN: 220620Hom.: 0 AF XY: 0.0000415 AC XY: 5AN XY: 120436
GnomAD4 exome AF: 0.0000346 AC: 50AN: 1446714Hom.: 0 Cov.: 33 AF XY: 0.0000418 AC XY: 30AN XY: 718516
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.650C>T (p.P217L) alteration is located in exon 5 (coding exon 3) of the RHBDD3 gene. This alteration results from a C to T substitution at nucleotide position 650, causing the proline (P) at amino acid position 217 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at